Ved 0, 4 mg cerivastatin monoterapi er indberetningsfrekvensen for rabdomyolyse større end efter lavere doser af cerivastatin.
With 0.4 mg cerivastatin monotherapy, the reporting rate of rhabdomyolysis is greater than that seen with lower doses of cerivastatin.